| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |